Stereotactic body radiotherapy to lymph nodes in oligoprogressive castration-resistant prostate cancer patients: a post hoc analysis from two phase I clinical trials

In conclusion, the efficacy in terms of LC of SBRT/SRS in patients with nodal metastases from PC was confirmed. Moreover, this analysis suggests the efficacy in terms of PFS and NEST-FS also in the setting of oligoprogressive PC. In fact, about one-third of patients were free from progressive disease and two-third of subjects did not require hormonal therapy switch or discontinuation three years after treatment.PMID:34651242 | DOI:10.1007/s10585-021-10126-7

Source: Clinical Prostate Cancer - October 15, 2021 Category: Cancer & Oncology Authors: D Pezzulla G Macchia S Cilla M Buwenge M Ferro P Bonome C Romano A Zamagni V Valentini A G Morganti F Deodato Source Type: research